Yyba (as Pld) - Welmate - Urinary Pain Relief (73581-909)
ad034f45-2852-f3c9-e053-2a95a90a38cb
34390-5
HUMAN OTC DRUG LABEL
Drug Facts
Composition & Product
Identifiers & Packaging
Description
Active ingredient (in each tablet) Phenazopyridine Hydrochloride 99.5 mg
Medication Information
Warnings and Precautions
Please read insert for important precautions.
Ask a doctor before use if you have:
■ kidney disease
■ allergies to foods, preservatives or dyes
■ had a hypersensitive reaction to Phenazopyridine Hydrochloride
Do not useif you have Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency unless approved by your physician.
When using this product
■ stomach upset may occur, taking this product with or after meals may reduce stomach upset
■ your urine will become reddish-orange in color. This is not harmful, but care should be taken to avoid staining clothing or other items.
Stop use and ask a doctor if
■ your symptoms last for more than 2 days
■ you suspect you are having an adverse reaction to the medication
■ Long-term adminitration of phenazopyridine hydrochloride has induced neoplasia in rats (large instestine) andmice (liver). Although no association between phenazopyridine hydrochloride and human enoplasia has beeen reported, adequate epidemiological studies along these lines have not been conducted.
If pregnant or breast-feeding,ask a health professional before use. A pregnancy test and consultation with a health professional if pregnancy is confirmed is recommended prior to use.
Keep out of reach of children.In case of an overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
Indications and Usage
Use Relief from urinary pain, burning, urgency and frequency associated with urinary tract infections.
Dosage and Administration
■Adults and children 12 years of age and over: Take 2 tablets 3 times daily with or after meals as needed for up to two days. Take with a full glass of water. Do not use for more than 2 days (12 tablets) without consulting a doctor
■ Children under 12: Do not use wihout consulting a doctor
Description
Active ingredient (in each tablet) Phenazopyridine Hydrochloride 99.5 mg
Section 42229-5
Size and color of tablets may vary.
*This product is not manufactured or distributed by the owner of the registered trademark AZO Urinary Pain Relief®.
Distributed by: Wellspring
Airmont, NY 10952, USA
Section 50565-1
Keep out of reach of children.In case of an overdose, get medical help or contact poison Control Center right away.
Section 51727-6
pregelatinized starch, microcrystalline cellulose, maize (corn) starch, povidone, croscarmellose sodium, magnesium stearate, colloidal silicon dioxide, hydroxypropyl methylcellulose, polyethylene glycol
Section 51945-4
Section 53413-1
call toll-free 1-845-547-2667
Section 55105-1
Purpose
Urinary Tract Analgesic
Section 55106-9
Active ingredient (in each tablet)
Phenazopyridine Hydrochloride 99.5 mg
Section 60561-8
■ This product can interfere with laboratory tests including urine, glucose (sugar), and ketones tests
■ This product may stain contact lenses and other items if handled after touching tablets
■ long term administration of phenazopyridine HCI has induced neoplasia in rats (large intestine) and mice (liver). Although no association between phenazopyridine hydrochloride and human neoplasia has been reported, adequate epidemiological studies along these lines have not been conducted
■ Store at room temperature 15°-30°C (59°-86°F) in a dry place and protect from light
Structured Label Content
Indications and Usage (34067-9)
Use Relief from urinary pain, burning, urgency and frequency associated with urinary tract infections.
Dosage and Administration (34068-7)
■Adults and children 12 years of age and over: Take 2 tablets 3 times daily with or after meals as needed for up to two days. Take with a full glass of water. Do not use for more than 2 days (12 tablets) without consulting a doctor
■ Children under 12: Do not use wihout consulting a doctor
Warnings and Precautions (34071-1)
Please read insert for important precautions.
Ask a doctor before use if you have:
■ kidney disease
■ allergies to foods, preservatives or dyes
■ had a hypersensitive reaction to Phenazopyridine Hydrochloride
Do not useif you have Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency unless approved by your physician.
When using this product
■ stomach upset may occur, taking this product with or after meals may reduce stomach upset
■ your urine will become reddish-orange in color. This is not harmful, but care should be taken to avoid staining clothing or other items.
Stop use and ask a doctor if
■ your symptoms last for more than 2 days
■ you suspect you are having an adverse reaction to the medication
■ Long-term adminitration of phenazopyridine hydrochloride has induced neoplasia in rats (large instestine) andmice (liver). Although no association between phenazopyridine hydrochloride and human enoplasia has beeen reported, adequate epidemiological studies along these lines have not been conducted.
If pregnant or breast-feeding,ask a health professional before use. A pregnancy test and consultation with a health professional if pregnancy is confirmed is recommended prior to use.
Keep out of reach of children.In case of an overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
Section 42229-5 (42229-5)
Size and color of tablets may vary.
*This product is not manufactured or distributed by the owner of the registered trademark AZO Urinary Pain Relief®.
Distributed by: Wellspring
Airmont, NY 10952, USA
Section 50565-1 (50565-1)
Keep out of reach of children.In case of an overdose, get medical help or contact poison Control Center right away.
Section 51727-6 (51727-6)
pregelatinized starch, microcrystalline cellulose, maize (corn) starch, povidone, croscarmellose sodium, magnesium stearate, colloidal silicon dioxide, hydroxypropyl methylcellulose, polyethylene glycol
Section 51945-4 (51945-4)
Section 53413-1 (53413-1)
call toll-free 1-845-547-2667
Section 55105-1 (55105-1)
Purpose
Urinary Tract Analgesic
Section 55106-9 (55106-9)
Active ingredient (in each tablet)
Phenazopyridine Hydrochloride 99.5 mg
Section 60561-8 (60561-8)
■ This product can interfere with laboratory tests including urine, glucose (sugar), and ketones tests
■ This product may stain contact lenses and other items if handled after touching tablets
■ long term administration of phenazopyridine HCI has induced neoplasia in rats (large intestine) and mice (liver). Although no association between phenazopyridine hydrochloride and human neoplasia has been reported, adequate epidemiological studies along these lines have not been conducted
■ Store at room temperature 15°-30°C (59°-86°F) in a dry place and protect from light
Advanced Ingredient Data
Raw Label Data
All Sections (JSON)
Additional Information
Back to search View SPL set listing Open on DailyMed ↗
Source: dailymed · Ingested: 2026-02-15T12:06:42.442010 · Updated: 2026-03-14T23:09:37.690586